1055499

IPR Pharmaceuticals, Inc. — FEI 3003009422

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
June 14, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Canovanas, PR (United States)

Citations

IDCFRDescription
358521 CFR 211.110(a)Control procedures to monitor and validate performance